Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.

Robert Evans Alfred Kohan Robert MoldwinDaniel RadeckiTill GeibKenneth M Peters

Published in: Neurourology and urodynamics (2021)

These studies did not demonstrate a treatment effect of LiRIS 400 mg compared with placebo, either in patients with IC/BPS with HL, or in those without HL.

Keyphrases

double blind
spinal cord injury
open label
clinical trial
placebo controlled
phase iii
smoking cessation